Clinical Oncology
Volume 16, Issue 8 , Pages 575-576 , December 2004

Neutropenia occurring after starting gabapentin for neuropathic pain

  • E. Derbyshire

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: Dr Emma Derbyshire, GP Registrar to Dr K. Finlay, Rusthall Medical Centre, Nellington Road, Tunbridge Wells, Kent TN4 8UW. Tel: +44-1892-515779; Fax: +44-1892-532256.
    • ,
  • D. Martin

Received 7 May 2004 ,Revised 21 June 2004 ,Accepted 22 June 2004.

References 

  1. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in post herpetic neuralgia. Neurology. 1998;50:1837–1841
  2. Tremont-Lukats IW, Megeff C, Backonja MM. Anticonvulsants for neuropathic pain syndromes. Drugs. 2000;60:1029–1052
  3. Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 1998;29:233–249
  4. Shorvon S. Handbook of epilepsy treatment. Oxford: Blackwell Science Ltd; 2000;
  5. Attal N, Brasseur B, Parker F, et al. Effects of the anticonvulsant on peripheral and central neuropathic pain: a pilot study. Eur Neurol. 1998;40:191–200
  6. Anonymous. Key point summary of gabapentin. Medical Information Department, Pfizer Limited, June 2001.

PII: S0936-6555(04)00242-0

doi: 10.1016/j.clon.2004.06.015

Clinical Oncology
Volume 16, Issue 8 , Pages 575-576 , December 2004

Article Tools